Hengrui Pharma signed the agreement with Merck (NYSE: MRK) — known as MSD outside of the United States and Canada — for HRS-5346, its investigational oral small molecule Lipoprotein (a), or Lp (a), ...

China will continue to invest more in new computer chipmaking equipment than any other geographical region in 2025, despite a ...

SHENYANG -- German technology company Heraeus Group on Tuesday officially launched its new quartz manufacturing plant in ...

China released plans on Wednesday to expand its carbon trading market into the steel, cement and aluminium smelting ...

Mike Huckabee, President Donald Trump's nominee for U.S. ambassador to Israel, attempted to distance himself Tuesday from his ...

US consumer safety watchdogs say the recent surge in product warnings boils down to one word: China.

Contemporary Amperex Technology Co. Ltd. has received China’s approval to proceed with a potentially blockbuster share sale ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...

Pirelli & C. SpA may push main investor Sinochem to cut its stake in the Italian tiremaker as its board of directors looks to ...

Glencore International, a wholly-owned subsidiary of London-listed Glencore PLC, is one of the Chinese company's cornerstone investors and one of its biggest customers, Nanshan said. About 90% of the ...

Signal, a messaging app known for its end-to-end encryption and focus on privacy, is facing renewed scrutiny in an era where digital security is a growing concern. Questions about its ownership and ...